HUM - Public offerings

Humana Inc. (the "company") (NYSE:HUM) announced today the completion of its public offering of $1.0 billion in aggregate principal amount of fixed-to-fixed rate junior subordinated notes due 2056, at 6.625 percent of the principal amount (the "Junior Subordinated Notes Offering"). The company expects net proceeds from the Junior Subordinated Notes Offering will be approximately $986 million after deducting underwriters' discounts and estimated offering expenses. The company intends to use the net proceeds from the Junior Subordinated Notes Offering for general corporate purposes, which may include the repayment of existing indebtedness, including borrowings under its commercial paper pro

AM Best has assigned a Long-Term Issue Credit Rating of "bbb-" (Good) to the $1 billion, 6.625% fixed rate junior subordinated notes, due 2056, of Humana Inc. (Humana) (headquartered in Louisville, KY) (NYSE:HUM). The outlook assigned to this Credit Rating (rating) is stable. All other ratings of Humana and its subsidiaries remain unchanged. Humana expects to use the proceeds from the junior subordinated notes issuance for general corporate purposes, which may include repayment of existing indebtedness, including borrowings under its commercial paper program. AM Best expects the issuance to increase financial leverage slightly in the intermediate term. The company's financial leverage, as

Humana Inc. (the "company") (NYSE:HUM) announced today that it has priced a public offering of $1.0 billion in aggregate principal amount of fixed-to-fixed rate junior subordinated notes due 2056, at 100.000 percent of the principal amount (the "Junior Subordinated Notes Offering"). The Junior Subordinated Notes Offering is expected to close on March 9, 2026, subject to the satisfaction of customary closing conditions. The company expects net proceeds from the Junior Subordinated Notes Offering will be approximately $986 million after deducting underwriters' discounts and estimated offering expenses. The company intends to use the net proceeds from the Junior Subordinated Notes Offering f

AM Best has commented that the Long-Term Issue Credit Rating of "bbb" (Good) on the $1.25 billion 5.375% senior unsecured notes, due 2031, originally issued on March 13, 2024, by Humana Inc. (Humana) (headquartered in Louisville, KY) (NYSE:HUM) remains unchanged despite the additional notes being added as part of the same series. Humana has announced that it has issued an additional $250 million of senior unsecured notes under that offering, bringing the total to $1.5 billion. The outlook of the Credit Rating (rating) is stable. Humana expects to use the proceeds from the senior unsecured notes issuance for general corporate purposes, including the repayment of existing debt and short-term

Humana Inc. (the "company") (NYSE:HUM) announced today the completion of its public offering of $1.25 billion in aggregate principal amount of senior notes. These senior notes are comprised of $750 million of the company's 5.550 percent senior notes, due 2035, at 99.885 percent of the principal amount, and $500 million of the company's 6.000 percent senior notes, due 2055, at 98.951 percent of the principal amount (collectively, the "Senior Notes Offerings"). The company expects net proceeds from the Senior Notes Offerings will be approximately $1.231 billion after deducting underwriters' discounts and estimated offering expenses. The company intends to use the net proceeds from the Senior

AM Best has assigned a Long-Term Issue Credit Rating of "bbb" (Good) to the $750 million, 5.5% senior unsecured notes, due 2035, and the $500 million, 6.0% senior unsecured notes, due 2055, issued by Humana Inc. (Humana) (headquartered in Louisville, KY) (NYSE:HUM). The outlook assigned to these Credit Ratings (ratings) is stable. Humana's Long-Term Issuer Credit Rating of "bbb" (Good), its Long-Term IRs and the ratings of its insurance subsidiaries are unchanged. Humana expects to use the proceeds from the senior unsecured notes issuance for general corporate purposes, including the repayment of existing debt of $600 million, 4.5% senior unsecured notes maturing in April 2025, and short-t

Humana Inc. (the "company") (NYSE:HUM) announced today that it has priced a public offering of $1.25 billion in aggregate principal amount of senior notes. These senior notes are comprised of $750 million of the company's 5.550 percent senior notes, due 2035, at 99.885 percent of the principal amount and $500 million of the company's 6.000 percent senior notes, due 2055, at 98.951 percent of the principal amount (collectively, the "Senior Notes Offerings"). The Senior Notes Offerings are expected to close on March 5, 2025, subject to the satisfaction of customary closing conditions. The company expects net proceeds from the Senior Notes Offerings will be approximately $1.231 billion after

Humana Inc. (the "company") (NYSE:HUM) announced today the completion of its public offering of $2.25 billion in aggregate principal amount of senior notes. These senior notes are comprised of $1.25 billion of the company's 5.375 percent senior notes, due 2031, at 99.940 percent of the principal amount, and $1.00 billion of the company's 5.750 percent senior notes, due 2054, at 99.949 percent of the principal amount (collectively, the "Senior Notes Offerings"). The company expects net proceeds from the Senior Notes Offerings will be approximately $2.226 billion after deducting underwriters' discounts and estimated offering expenses. The company intends to use the net proceeds from the Sen

AM Best has assigned Long-Term Issue Credit Ratings (Long-Term IRs) of "bbb" (Good) to Humana Inc.'s (Humana) (headquartered in Louisville, KY) (NYSE:HUM) recently announced $1.25 billion 5.375% senior unsecured notes, due 2031, and $1 billion 5.75% senior unsecured notes, due 2054. In addition, AM Best has assigned indicative Long-Term IRs of "bbb" (Good) to senior unsecured issues, "bbb-" (Good) to subordinated issues and "bb+" (Fair) to preferred stock and of the recently filed shelf registration of Humana. The outlook assigned to these Credit Ratings (ratings) is stable. Concurrently, AM Best has withdrawn the ratings on the previous shelf registration, which expired. Humana is antici

Humana Inc. (the "company") (NYSE:HUM) announced today that it has priced a public offering of $2.25 billion in aggregate principal amount of senior notes. These senior notes are comprised of $1.25 billion of the company's 5.375 percent senior notes, due 2031, at 99.940 percent of the principal amount and $1.00 billion of the company's 5.750 percent senior notes, due 2054, at 99.949 percent of the principal amount (collectively, the "Senior Notes Offerings"). The Senior Notes Offerings are expected to close on March 13, 2024, subject to the satisfaction of customary closing conditions. The company expects net proceeds from the Senior Notes Offerings will be approximately $2.226 billion af

Humana Inc. (the "company") (NYSE:HUM) announced today the completion of its public offering of $1.35 billion in aggregate principal amount of senior notes. These senior notes are comprised of $500 million of the company's 5.750 percent senior notes, due 2028, at 99.830 percent of the principal amount, and $850 million of the company's 5.950 percent senior notes, due 2034, at 98.525 percent of the principal amount (collectively, the "Senior Notes Offerings"). The company expects net proceeds from the Senior Notes Offerings will be approximately $1.324 billion after deducting underwriters' discounts and estimated offering expenses. The company intends to use the net proceeds from the Senio

Humana Inc. (the "company") (NYSE:HUM) announced today that it has priced a public offering of $1.35 billion in aggregate principal amount of senior notes. These senior notes are comprised of $500 million of the company's 5.750 percent senior notes, due 2028, at 99.830 percent of the principal amount, and $850 million of the company's 5.950 percent senior notes, due 2034, at 98.525 percent of the principal amount (collectively, the "Senior Notes Offerings"). The Senior Notes Offerings are expected to close on November 9, 2023, subject to the satisfaction of customary closing conditions. The company expects net proceeds from the Senior Notes Offerings will be approximately $1.324 billion a

Humana Inc. (the "company") (NYSE:HUM) announced today the completion of its public offering of $1.25 billion in aggregate principal amount of senior notes. These senior notes are comprised of $500 million of the company's 5.700 percent senior notes, due 2026, at 99.984 percent of the principal amount and $750 million of the company's 5.500 percent senior notes, due 2053, at 96.431 percent of the principal amount (collectively, the "Senior Notes Offerings"). The company expects net proceeds from the Senior Notes Offerings will be approximately $1.211 billion after deducting underwriters' discounts and estimated offering expenses. The company intends to use the net proceeds from the Senior

Humana Inc. (the "company") (NYSE:HUM) announced today that it has priced a public offering of $1.25 billion in aggregate principal amount of senior notes. These senior notes are comprised of $500 million of the company's 5.700 percent senior notes, due 2026, at 99.984 percent of the principal amount and $750 million of the company's 5.500 percent senior notes, due 2053, at 96.431 percent of the principal amount (collectively, the "Senior Notes Offerings"). The Senior Notes Offerings are expected to close on March 13, 2023, subject to the satisfaction of customary closing conditions. The company expects net proceeds from the Senior Notes Offerings will be approximately $1.211 billion after

Humana Inc. (the "company") (NYSE:HUM) announced today the completion of its public offering of $1.25 billion in aggregate principal amount of senior notes. These senior notes are comprised of $500 million of the company's 5.750 percent senior notes, due 2028 (the "2028 notes"), at 99.705 percent of the principal amount and $750 million of the company's 5.875 percent senior notes, due 2033 (the "2033 notes"), at 99.508 percent of the principal amount (collectively, the "Senior Notes Offerings"). The company expects net proceeds from the Senior Notes Offerings will be approximately $1.232 billion after deducting underwriters' discounts and estimated offering expenses. The company intends to

AM Best has assigned a Long-Term Issue Credit Rating (Long-Term IR) of "bbb-" (Good) to Humana Inc.'s (Humana) (headquartered in Louisville, KY) (NYSE:HUM) recently announced $500 million of 5.75% senior unsecured notes due March 1, 2028, and $750 million of 5.875% senior unsecured notes due March 1, 2033. The outlook assigned to these Credit Ratings (rating) is stable. Humana's Long-Term Issuer Credit Rating of "bbb-" (Good), its existing Long-Term IRs and the ratings of its insurance subsidiaries are unchanged. It is anticipated that the proceeds of this debt issue will be used for repayment of debt maturities coming due in December totaling $1 billion, as well as for general corporate p

Humana Inc. (the "company") (NYSE:HUM) announced today that it has priced a public offering of $1.25 billion in aggregate principal amount of senior notes. These senior notes are comprised of $500 million of the company's 5.75 percent senior notes, due 2028 (the "2028 notes"), at 99.705 percent of the principal amount and $750 million of the company's 5.875 percent senior notes, due 2033 (the "2033 notes"), at 99.508 percent of the principal amount (collectively, the "Senior Notes Offerings"). The Senior Notes Offerings are expected to close on November 22, 2022, subject to the satisfaction of customary closing conditions. The company expects net proceeds from the Senior Notes Offerings wi

AM Best has assigned a Long-Term Issue Credit Rating (Long-Term IR) of "bbb-" (Good) to Humana Inc.'s (Humana) (headquartered in Louisville, KY) (NYSE:HUM) recently announced $750 million of 3.70% senior unsecured notes due 2029. The outlook assigned to the Credit Rating (rating) is stable. Humana's Long-Term Issuer Credit Rating of "bbb-" (Good), its existing Long-Term IRs and the ratings of its insurance subsidiaries are unchanged. It is anticipated that the proceeds of this issue will be used for general corporate purposes including debt maturities and repayment of outstanding short-term borrowings. As a result, AM Best expects that this issue will be neutral to Humana's financial lever

Humana Inc. (the "company") (NYSE:HUM) announced today the completion of its public offering of $750 million aggregate principal amount of the company's 3.700 percent senior notes, due 2029 (the "Senior Notes Offering"). The company expects net proceeds from the Senior Notes Offering will be approximately $741.1 million, after deducting underwriters' discounts and estimated offering expenses. The company intends to use the net proceeds from the Senior Notes Offering for general corporate purposes, which may include the repayment of existing indebtedness, including borrowings under the company's commercial paper program. Citigroup Global Markets Inc. and Morgan Stanley & Co. LLC acted as a

Humana Inc. (the "company") (NYSE:HUM) announced today that it has priced a public offering of $750 million aggregate principal amount of the company's 3.700 percent senior notes, due 2029 (the "Senior Notes Offering"). The Senior Notes Offering is expected to close on March 23, 2022, subject to the satisfaction of customary closing conditions. The company expects net proceeds from the Senior Notes Offering will be approximately $741.1 million, after deducting underwriters' discounts and estimated offering expenses. The company intends to use the net proceeds from the Senior Notes Offering for general corporate purposes, which may include the repayment of existing indebtedness, including b

Humana Inc. (the "company") (NYSE:HUM) announced today the completion of its public offering of $3.0 billion in senior notes. These senior notes are comprised of $1,500 million of the company's 0.650 percent senior notes, due 2023 (the "2023 notes"), at 99.933 percent of the principal amount, $750 million of the company's 1.350 percent senior notes, due 2027 (the "2027 notes"), at 99.905 percent of the principal amount and $750 million of the company's 2.150 percent senior notes, due 2032 (the "2032 notes"), at 99.804 percent of the principal amount (collectively, the "Senior Notes Offerings"). The company expects net proceeds from the Senior Notes Offerings will be approximately $2.973 bi

AM Best has assigned Long-Term Issue Credit Ratings (Long-Term IR) of "bbb-" (Good) to Humana Inc.'s (Humana) (headquartered in Louisville, KY) (NYSE:HUM) recently announced $750 million 1.350% senior unsecured notes due 2027, the $750 million 2.150% senior unsecured notes due 2032 and the $1.5 billion 0.65% senior unsecured notes due 2023. The outlook assigned to these Credit Ratings (ratings) is stable. Humana's Long-Term Issuer Credit Rating of "bbb-" (Good), its existing Long-Term IRs and the ratings of its insurance subsidiaries are unchanged. Net proceeds from the debt issuance along with $300 million cash at the company and borrowings of $500 million from the term loan will be used

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) today reported consolidated pretax results and results per common share for the quarter ended December 31, 2020 (4Q20) versus the quarter ended December 31, 2019 (4Q19) and for the year ended December 31, 2020 (FY 2020) versus the year ended December 31, 2019 (FY 2019) as noted in the tables below. Consolidated (loss) income before income taxes and equity in earnings (pretax (loss) income) In millions 4Q20 (a)   4Q19 (b) FY 2020 (c)   FY 2019 (d) Generally Accepted Accounting Principles (GAAP) ($458)   $593   $4,600   $3,456   Amortization associated with identifiable intang